MARYANN RYAN: Open Payments
NPI 1336463058 · WARWICK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,343 in 68 payments from 11 companies in 2025. Trend: 2023 $911 · 2024 $853 · 2025 $1,343
Food & beverage: $1,343
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $421 |
| Alkermes, Inc. | 18 | $381 |
| Corium, LLC | 5 | $127 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $79 |
| Teva Pharmaceuticals USA, Inc. | 5 | $73 |
| Neurocrine BioSciences, Inc. | 3 | $69 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Tris Pharma Inc | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
Products named: VRAYLAR, ARISTADA, Azstarys, LYBALVI, CAPLYTA, AUSTEDO XR, INGREZZA, REXULTI.
Industry payments across NY — which companies pay providers there.
